On Oct. 29, on behalf of the National Forum Value & Access Collaborative and partners, Director of Programs Jen Childress presented comments to the Institute for Clinical and Economic Review’s (ICER’s) Midwest Comparative Effectiveness Public Advisory Council meeting on its review of high blood pressure treatments.
The comments were based on earlier consensus feedback provided by the Value & Access Collaborative, whose members represent patients, clinical providers, payers, purchasers, public health, and pharmaceutical and biotechnology stakeholders.
